CD44-Targeted Lipid Polymer Hybrid Nanoparticles Enhance Anti-Breast Cancer Effect of Cordyceps militaris Extracts

dc.contributor.authorSuksiriworapong J.
dc.contributor.authorPongprasert N.
dc.contributor.authorBunsupa S.
dc.contributor.authorTaresco V.
dc.contributor.authorCrucitti V.C.
dc.contributor.authorJanurai T.
dc.contributor.authorPhruttiwanichakun P.
dc.contributor.authorSakchaisri K.
dc.contributor.authorWongrakpanich A.
dc.contributor.otherMahidol University
dc.date.accessioned2023-07-17T18:03:28Z
dc.date.available2023-07-17T18:03:28Z
dc.date.issued2023-06-01
dc.description.abstractThis study aimed to improve the anticancer effect of Cordyceps militaris herbal extract (CME) on breast cancer cells with hyaluronic acid (HYA) surface-decorated lipid polymer hybrid nanoparticles (LPNPs) and evaluate the applicability of a synthesized poly(glycerol adipate) (PGA) polymer for LPNP preparation. Firstly, cholesterol- and vitamin E-grafted PGA polymers (PGA-CH and PGA-VE, respectively) were fabricated, with and without maleimide-ended polyethylene glycol. Subsequently, CME, which contained an active cordycepin equaling 9.89% of its weight, was encapsulated in the LPNPs. The results revealed that the synthesized polymers could be used to prepare CME-loaded LPNPs. The LPNP formulations containing Mal-PEG were decorated with cysteine-grafted HYA via thiol-maleimide reactions. The HYA-decorated PGA-based LPNPs substantially enhanced the anticancer effect of CME against MDA-MB-231 and MCF-7 breast cancer cells by enhancing cellular uptake through CD44 receptor-mediated endocytosis. This study demonstrated the successful targeted delivery of CME to the CD44 receptors of tumor cells by HYA-conjugated PGA-based LPNPs and the new application of synthesized PGA-CH- and PGA-VE-based polymers in LPNP preparation. The developed LPNPs showed promising potential for the targeted delivery of herbal extracts for cancer treatment and clear potential for translation in in vivo experiments.
dc.identifier.citationPharmaceutics Vol.15 No.6 (2023)
dc.identifier.doi10.3390/pharmaceutics15061771
dc.identifier.eissn19994923
dc.identifier.scopus2-s2.0-85163776294
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/87934
dc.rights.holderSCOPUS
dc.subjectPharmacology, Toxicology and Pharmaceutics
dc.titleCD44-Targeted Lipid Polymer Hybrid Nanoparticles Enhance Anti-Breast Cancer Effect of Cordyceps militaris Extracts
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85163776294&origin=inward
oaire.citation.issue6
oaire.citation.titlePharmaceutics
oaire.citation.volume15
oairecerif.author.affiliationUniversity of Nottingham
oairecerif.author.affiliationMahidol University
oairecerif.author.affiliationKing Mongkut's University of Technology Thonburi

Files

Collections